AECC Clinical Studies Grants 2027: Up to €1 Million

AECC Clinical Studies Grants 2027: Up to €1 Million

Due Date: 01/28/2027

The AECC Clinical Studies Grants 2027 provide up to €1 million over five years for multicenter cancer research independent of pharmaceutical industry sponsorship. Offered by the Scientific Foundation of the Spanish Association Against Cancer, the call supports studies addressing clinical needs or testing approaches that could change practice.

Eligible work includes phase II–III trials, predictive biomarker studies, and research into early diagnosis, surgical approaches, new technologies or palliative care. The program brings clinical and translational teams together around a shared study protocol.

Eligibility and Project Criteria

  • Applicants must be research group leaders working at eligible nonprofit healthcare institutions.
  • Host institutions must be affiliated with or contracted by Spain’s National Health System.
  • Studies must involve multiple centers.
  • Projects must combine clinical and translational expertise.
  • Participating centers must follow a single study protocol.
  • Projects must be independent of pharmaceutical industry sponsorship and address a clinical question within the call’s scope.

Funding Details

  • Maximum award: €1,000,000.
  • Duration: Five years.
  • Annual funding cap: €200,000.

Deadline

  • Applications opened: November 12, 2026.
  • Application deadline: January 28, 2027, at 3:00 p.m. mainland Spain time (CET).

Further Information